Development of a dual energy CT based model to assess response to treatment in patients with high grade serous ovarian cancer: a pilot cohort study

Zena Alizzi,Andrew Gogbashian,Emmanouil Karteris,Marcia Hall
DOI: https://doi.org/10.1186/s40644-023-00579-2
IF: 5.605
2023-06-16
Cancer Imaging
Abstract:In patients with cancer, the current gold standard for assessing response to treatment involves measuring cancer lesions on computed tomography (CT) imaging. The percentage change in size of specific lesions determines whether patients have had a complete/partial response or progressive disease, according to RECIST criteria. Dual Energy CT (DECT) permits additional measurements of iodine concentration, a surrogate marker of vascularity. Here we explore the role of changes in iodine concentration within cancer tissue on CT scans to assess its suitability for determining treatment response in patients with high grade serous ovarian cancer (HGSOC).
oncology,radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?